Jpmorgan Chase & CO Icad Inc Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Icad Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,063 shares of ICAD stock, worth $1,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,063Holding current value
$1,264% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ICAD
# of Institutions
56Shares Held
6.29MCall Options Held
18.2KPut Options Held
37.5K-
Portolan Capital Management, LLC Boston, MA1.21MShares$1.44 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.09MShares$1.29 Million0.0% of portfolio
-
First Eagle Investment Management, LLC702KShares$834,8140.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny491KShares$584,4230.0% of portfolio
-
Black Rock Inc. New York, NY353KShares$419,5010.0% of portfolio
About ICAD INC
- Ticker ICAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,333,900
- Market Cap $30.1M
- Description
- iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...